Claritas iPETTM Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic Goods Administration (TGA) has approved the software device, Claritas iPETTM for supply in Australia.This clearance from TGA in Australia further expands the reach and use of Claritas iPETTM, already cleared and used in several jurisdictions. This software tool which is agnostic to equipment type and manufacturer, and which integrates into existing hospital systems, is being used to enhance noisy and unclear Positron Emission Tomography (PET) scans for improved visibility and sharpness. The methods implemented in Claritas iPETTM ensures fine lesions are ...Full story available on Benzinga.com